Skip to main content
Clinical Trials/NCT03148314
NCT03148314CompletedPhase 2

Home-Based Extended Low Dose Buccal Misoprostol Versus Hospital-Based Standard Vaginal Dose In Management Of First Trimester Missed Abortion.

Assiut University1 site in 1 country140 target enrollmentStarted: July 1, 2017Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
140
Locations
1
Primary Endpoint
Percentage of patients with complete abortion (success rate).

Study Overview

Brief Summary

The world health organization defined abortion or miscarriage as : the expulsion or extraction from its mother of a fetus or an embryo weighting 500 grams or less ,or any other wise product of gestation of any weight irrespective of gestational age and weather or not there is evidence of life and weather or not the abortion was spontaneous or induced Miscarriage is the most common complication of pregnancy occurring in 10-20% of clinically recognized pregnancies (Bag. It is estimated that around 40% of early pregnancies result in miscarriage. A large majority of those are lost before the menstrual period is missed. More than 80%of abortions occur in first 12 weeks of pregnancy, and the rate decrease there after For clinical purposes: abortion is subdivided into: threatened abortion, inevitable abortion, incomplete abortion ,missed abortion ,septic abortion ,and recurrent abortion

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
20 Years to 40 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • single dead fetus up-to 12 weeks.
  • no low lying placenta
  • no scarred uterus
  • no or mild bleeding
  • no evidence of infection
  • accepting to participate in the study.

Exclusion Criteria

  • Advanced hepatic diseases .
  • Suspected molar pregnancy
  • Ectopic pregnancy or pregnancy of unknown location
  • Haemodynamically unstable with significant anaemia ie Hb<10
  • Uncontrolled severe asthma
  • Chronic adrenal failure
  • Known or suspected heart disease
  • Haemoglobinopathies
  • Haemorrhagic disorders and anti-coagulation therapy (aspirin accepted)
  • Adrenal suppression and long term glucocorticoid therapy (may require corticosteroid)
  • Patient living in remote areas with difficulty in accessing hospital

Arms & Interventions

hospital- based vaginal misoprostol

Active Comparator

hospital- based vaginal misoprostol

Intervention: vaginal misoprostol (Drug)

extended low dose oral misoprostol

Active Comparator

extended low dose oral misoprostol

Intervention: buccal/sublingual misoprostol (Drug)

Outcomes

Primary Outcomes

Percentage of patients with complete abortion (success rate).

Time Frame: 1 week

Secondary Outcomes

  • Number of misoprostol doses(1 week)
  • induction-abortion time(1 week)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mohammed Khairy Ali

Lecturer of obstetrics and gynecology

Assiut University

Study Sites (1)

Loading locations...

Similar Trials